Oxford Textbook of Oncology

Edited by David J. Kerr, Professor of Cancer Medicine, Nuffield Division of Clinical Laboratory Sciences, Nuffield Department of Medicine, University of Oxford, Oxford, UK, Honorary Professor of Oncology, Xiamen and 2nd Military Universities, China, Honorary Professor, Seoul National University, Korea, Daniel G. Haller, Professor Emeritus, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA, Cornelis J. H. van de Velde, Professor of Surgery and Head, Department of Surgical Oncology, Leiden University Medical Center, The Netherlands, and Michael Baumann, Cancer Research Center (DKFZ), Heidelberg, Germany and Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany

Neil K. Aaronson, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Ann Adams, Massachusetts General Hospital, Department of Surgery, Boston, MA, USA
Felipe Ades-Moraes, Hospital Albert Einstein, São Paulo, Brazil
Ahmed Ashour Ahmed, Nuffield Department of Obstetrics and Gynaecology, University of Oxford, UK
Richard W. Ahn, Northwestern University, Deptartment of Chemistry, Evanston, IL, USA
H. Richard Alexander, Jr., University of Maryland School of Medicine, Baltimore, MD, USA
Peter J Allen, David M. Rubenstein Center for Pancreatic Cancer Research; Memorial Sloan Kettering Cancer Centre, New York, USA
Fabrice Andre, INSERM (Institut National des Sciences et de la Recherche Médicale); Institut Gustave Roussy, Villejuif, France
Olaf Ansorge, Nuffield Department of Clinical Neurosciences, University of Oxford, UK
Nadir Arber, Integrated Cancer Prevention Center (ICPC), The Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Monica Arnedos, Department Of Medical Oncology, Institut Gustave Roussy, Villejuif, France
Yull Arriaga, University of Texas Southwestern Medical Center, Dallas, TX, USA
Hatem A. Azim Jr, Institut Jules Bordet, Breast Cancer Translational Research Laboratory, Brussels, Belgium
Irène Baccelli, Institute for Research in Immunology and Cancer, Université de Montréal, Canada
Elizabeth Baldini, Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Hideaki Bando, Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan
Udai Banerji, The Institute of Cancer Research and The Royal Marsden, Drug Development Unit, London, UK
Dario Baratti, Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
Gustavo Baretton, Institute for Pathology, Medical Faculty, Technical University Dresden, Germany
Michael Baumann, Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden; OncoRay - National Center for Radiation Research in Oncology, Germany
Regina Beets-Tan, Department of Radiology, Maastricht University Medical and Oncology Center, The Netherlands
Frank Bergmann, Institute of Pathology, University Hospital, Heidelberg, Germany
Ravi Bhatia, Director, Division of Hematology-Oncology, and Professor, Department of Medicine, University of Alabama Birmingham, Birmingham, AL, USA
Claire Blesing, Department of Oncology, Oxford Cancer Centre, Churchill Hospital, UK
Walter Bodmer, Weatherall Institute of Molecular Medicine and Department of Oncology, University of Oxford, John Radcliffe Hospital, UK
Petra G. Boelens, Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
K. Borgmann,
Ulrich Bork, Department of General, Visceral and Transplant Surgery, University of Heidelberg, Germany
Chris Boshoff, Research Department of Cancer Bio, UCL Cancer Institute, Faculty of Medical Sciences, University College London, UK
Michael Brada, The Clatterbridge Cancer Centre, Liverpool, and the Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK
Eduardo Bruera, Department of Palliative Care & Rehabilitation Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Thomas B Brunner, Department of Radiation Oncology, University Hospitals Freiburg, Freiburg im Breisgau, Germany
Markus W Büchler, Department of General, Visceral and Transplant Surgery, University of Heidelberg, Germany
Raphael Bueno, Division of Thoracic Surgery, Brigham and Women's Hospital, and Professor of Surgery, Harvard Medical School, Boston, MA, USA
Rebecca Bütof, Department of Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany
Simon Mark Carr, Laboratory of Cancer Biology, Department of Oncology, University of Oxford, UK
Paolo Giovanni Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
Bjoern Chapuy, Dana-Farber Cancer Institute, Boston, MA, USA
Lucian Chirieac, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
Terence C Chua, Ryde Hospital, Syndey, NSW, Australia
Christine H. Chung, Department of Oncology, Johns Hopkins University, Baltimore, MD, USA
David Church, Wellcome Trust Centre for Human Genetics, Oxford, UK
Stephanie E Combs, Department of Radiation Oncology, University Hospital of Heidelberg, Germany
Eithne Costello, The Clatterbridge Cancer Centre, Liverpool, and the Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK
Sarah E. Coupland, Dept. Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, England
Amanda S Coutts, Department of Oncology, University of Oxford, UK
David Cunningham, Department of Medicine, Royal Marsden NHS Foundation Trust, Sutton, UK
Diona Damian, Dermatology, University of Sydney and Melanoma Institute Australia, Sydney, NSW, Australia
Faith Davies, The Royal Marsden NHS Foundation Trust, London, UK
Wouter de Herder, Erasmus MC, Department of Internal Medicine, section of Endocrinology, Rotterdam, The Netherlands
Jean de la Rosette, Department of Urology, AMC University Hospital, Amsterdam, The Netherlands
Assunta de Rienzo, Thoracic Surgery Oncology Laboratory at Brigham and Women's Hospital, and Instructor in Surgery, Harvard Medical School, Boston, MA, USA
Juergen Debus, Heidelberg Institute Radiation Oncology (HIRO), and German Consortium Translational Oncology (DKTK), Germany
Angelo Paolo Dei Tos, General Hospital of Treviso, Department of Oncology, Treviso, Italy
Suzette Delaloge, Centre de Lutte Contre le Cancer (CLCC), Institut Gustave Roussy, France
Axel Denz, Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
Marcello Deraco, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Christophe Deroose, Nuclear Medicine, University Hospitals Leuven, and Department of Imaging & Pathology, KU Leuven, Belgium
Andreas Dietz, ENT Department, University Hospital of Leipzig, Germany
Ekkehard Dikomey, Radiobiology & Experimental Radiooncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Piet Dirix, Iridium Cancer Network, GZA St Augustinus Hospital, Department of Radiation Oncology, Antwerpen, Belgium
Rafal Dziadziuszko, Dept. of Oncology and Radiotherapy, Medical University of Gda?sk, Gda?sk, Poland
Adel K El-Naggar, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Jonathan Evans, Department of Radiology, The Royal Liverpool University Hospital, Liverpool, UK
Andrew Evans, Dundee University, Dundee, UK
Daniel G Ezra, Moorfields Eye Hospital, Moorfields, and UCL Institute of Ophthalmology BMRC, London, UK
Peter Fayers, Institute of Applied Health Sciences, University of Aberdeen, UK, and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway,
Kathryn Field, Royal Melbourne Hospital, and Clinical Research Fellow, Ludwig Institute Cancer Research, Melbourne, VIC, Australia
Adele Fielding, UCL Cancer Institute, London, UK
John Fitzpatrick (deceased), Irish Cancer Society, Dublin, Republic of Ireland
Stephen B Fox, Peter MacCallum Cancer Centre, Melbourne, and Department of Pathology, University of Melbourne, Australia
Arthur E. Frankel, Dallas, TX, USA
Stefan Fritz, Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Germany
Toral Gathani, Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, UK
Kevin Gatter, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, Oxford, UK
Ritu Gill, Department of Radiology, Harvard Medical School, and Associate Radiologist, Thoracic Radiology, Brigham And Women's Hospital, Boston, MA, USA
Oliver Gimm, Department of Clinical and Experimental Medicine, Division of Clinical Sciences, Linköping University, Linköping, Sweden
Christian Gisselbrecht, Institut d'Hématologie, Hôpital Saint Louis, Paris, France
Bengt Glimelius, Oncology Section, Dept of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
Sarah E.B. Goltz, Principal, Sage Innovation, Brooklyn, NY, USA
Mary Gospodarowicz, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada
Sebastien Gouy, Gustave Roussy, Villejuif, France
Vincent Gregoire, Department of Radiation Oncology, UCL St-Luc University Hospital, Catholic University of Louvain, Brussels, Belgium
Alessandro Gronchi, Sarcoma Service, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Ashley Grossman, Professor of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, UK
Marco Guzzo, Fondazione IRCCS "Istituto Nazionale dei Tumori ", Milan, Italy
Daniel Haller, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Christopher Halloran, NIHR Pancreas Biomedical Research Unit, DMCCM, ITM, University of Liverpool, Liverpool, UK
Marc Hamoir, Cancer Center Cliniques universitaires Saint-Luc, Brussels, Belgium
Douglas Hanahan, Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland
D. Paul Harkin, School of Medicine, Dentistry and Biomedical Sciences, and Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK
Adrian L Harris, Molecular Oncology Laboratories, Oxford University Department of Oncology, Weatherall Institute of Molecular Medicine, Oxford, UK
Raffit Hassan, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Karin Haustermans, Department of Radiation Oncology, University Hospitals Leuven, Department of Oncology, KULeuven, Belgium
Priya Healey, Royal Liverpool and Broadgreen University Hospital, Liverpool, UK
Jack Henkin, Northwestern University, Center for Developmental Therapeutics, Evanston, IL, USA
Alexander Heriot, Department of Surgical
Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
C Simon Herrington, Division of Cancer Research, Ninewells Hospital and Medical School, Dundee, UK
Devendra Hiwase, Haematology Department, Institute of Medical and Veterinary Science, Adelaide, SA, Australia
David Hodgson, Department of Radiation Oncology, University of Toronto, Canada
Dieter Hoelzer, ONKOLOGIKUM Frankfurt | am Museumsufer, Frankfurt, Germany
David Hui, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Tim Illidge, Institute of Cancer Sciences, UNiversity of Manchester, Manchester Academic Health Science Centre, Manchester, UK
David Jackman, Harvard Medical School, Medical Director of Clinical Pathways, Dana-Farber Cancer Institute, Boston, MA, USA
Patrick Johnston, President and Vice-Chancellor, Queen's University Belfast, UK
Ellen Kampman, WU Agrotechnology & Food Sciences, Division of Human Nutrition, Wageningen University and Research Centre, The Netherlands
Richard Kefford, Faculty of Medicine, Macquarie University, and, Melanoma Institute Australia, Sydney, NSW, Australia
Richard Kennedy, Centre for Cancer Research and Cell Biology, Queen's University of Belfast, and Vice President and Head of Research, Almac Diagnostics, UK
Keith M Kerr, Department of Pathology, Aberdeen University Medical School, Foresterhill, Aberdeen, UK
Rachel Kerr, Department of Oncology, University of Oxford, UK
David Kerr, Nuffield Division of Clinical Laboratory Sciences, Nuffield Department of Medicine, University of Oxford, UK
Takahiro Kinoshita, National Cancer Center, Tokyo, Japan
Stefan Knapp, University of Oxford, Nuffield Department of Clinical Medicine, Target Discovery Institute, UK
Jon Knowles,
Mechthild Krause, Deptartment of Radiation Oncology and OncoRay, Medical Faculty and University Hospital Carl Gustav Carus, German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ) Heidelberg, Germany
Malte Kriegs, University of Hamburg, Germany
Frank Kroschinsky, Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Germany
Yasutoshi Kuboki, Japanese Foundation for Cancer Research, Tokyo, Japan
Lalit Kumar, Department of Medical Oncology, All India Institute of Medical Sciences, New Dehli, India
Nicholas La Thangue, Department of Oncology, University of Oxford, UK
Sigurd Lax, Institute for Pathology, General Hospital Graz West, Graz, Austria
Eric Leblanc, Lille Cancer Center, Centre Oscar Lambert (COL), Lille, France
C. René Leemans, Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center, Amsterdam, The Netherlands
Jean-Louis Lefebvre, Lille Cancer Center, Centre Oscar Lambert (COL), Lille, France
Toni Lerut, University Hospital Gasthuisberg, KULeuven, Belgium
Ross L Levine, Memorial Sloan Kettering Cancer Center, New York, USA
Lisa Licitra, Istituto Nazionale dei Tumori, Milan, Italy
Bolin Liu, Department of Neurosurgery, Xijing Institute of Clinical Neuroscience, Xijing Hospital, Fourth Military Medical University, Xi'an, China
Shujuan Liu, Weatherall Institute of Molecular Medicine and Nuffield Department of Obstetrics and Gynaecology, University of Oxford, UK, and Department of Obstetrics and Gynaecology, Xijing Hospital, The Fourth Military Medical University, China,
Julian Lob-Levyt, Malaria Consortium, and Senior Vice President, DAI, London, UK
GPM Luyten, Leiden University Medical Center, The Netherlands
Henry Lynch, Department of Preventive Medicine, Creighton University, Omaha, NE, USA
Jane F Lynch (deceased), Formerly of the Department of Preventive Medicine, Creighton University, Omaha, NE, USA
Hemant Malhotra, Division of Medical Oncology, RK Birla Cancer Center, SMS Medical College Hospital, Jaipur, India
Pankaj Malhotra, Department of Internal Medicine, Postgraduate Institute of Medical Education & Research, Chandigarh, India
Mohandas Mallath, Department of Digestive Diseases, Tata Medical Centre, Kolkata, West Bengal, India
Sandra Maniam, Department of Human Anatomy, Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang, Malaysia
W Mansour,
Andrew P Mazar, Northwestern University, Chicago, USA
Donald McMillan, Academic Unit of Surgery, School of Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow Royal Infirmary, UK
Alexander Menzies, Melanoma Institute Australia, University of Sydney, Australia
Michael Michael, Peter MacCallum Cancer Centre, Division of Cancer Medicine, Colorectal Tumour Stream, Melbourne, VIC, Australia
Tetsuya Mitsudomi, Department of Surgery, Division of Thoracic Surgery, Faculty of Medicine, Kinki University, Osaka-Sayama, Japan
Annette Moll, VU University Medical Center, Amsterdam, The Netherlands
Gareth Morgan, The Institute of Cancer Research, and Consultant Haematologist, The Royal Marsden NHS Foundation Trust, London, UK
Philippe Morice, Gustave Roussy, Universite Paris XI, Villejuif, France
Charles G. Mullighan, Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, US
Asif Muneer, University College Hospital, London, UK
Philippe Nafteux, Department of Thoracic Surgery, University Hospitals Leuven, Belgium
Iris Nagtegal, Department of Pathology, Radboud umc, Nijmegen, The Netherlands
Fabrice Narducci, Lille Cancer Center, Centre Oscar Lambert (COL), Lille, France
John Neoptolemos, Department of Molecular and Clinical Cancer Medicine at the University of Liverpool, Royal Liverpool and Broadgreen University Hospitals NHS Trust, UK
Sam Ngan, Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
Atsushi Ochiai, National Cancer Center, Tokyo, Japan
Yishai Ofran, Hematology Department, Rambam Health Care Campus, Haifa, Israel
Thomas V O'Halloran, Charles E. & Emma H. Morrison Professor of Chemistry, Professor of Molecular Biosciences, and Founding Director, Chemistry of Life Processes Institute and Department of Chemistry, Northwestern University, Evanston, IL, USA
Atsushi Ohtsu, National Cancer Center Hospital East, Kashiwa, Japan
Paula A. Oliveira, CITAB, Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro, Vila Real, Portugal, Vila Real, Portugal
Michael Ong, Division of Medical Oncology, University of Ottawa, Faculty of Medicine, Ottawa, ON, Canada
Rainer Ordemann, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
Brian O'Sullivan, Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada
Lars P hlman, Department of Surgery, University Hospital Uppsala, Sweden
Daniel Palmer, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
Ulrich-Frank Pape, Charité University Medicine Berlin, Dept. of Hepatology and Gastroenterology, Berlin, Germany
Allyson Parry, John Radcliffe Hospital, Oxford, UK
Ann H. Partridge, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Nicholas Pavlidis, University of Ioannina, Ioannina, Grece
Charlotte Pawlyn, The Institute of Cancer Research, London, UK
Jacob Pe'er, Department of Opthalmology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
Marzia Pennati, Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
George Pentheroudakis, Medical School, University of Ioannina, Ioannina, Greece
Jeffrey Peppercorn, MGH Cancer Survivorship Program, Massachusetts General Hospital, Concord, MA, USA
Federica Perrone, Laboratory of Experimental Molecular Pathology, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Solange Peters, Medical Oncology, Oncology Department, CHUV, Lausanne, Switzerland
C. Petersen,
Francesco Pezzella, Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, UK
Martine Piccart, Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
Stefano Pileri, Bologna University, European Institute of Oncology, Milan, Italy
Puneet Plaha, John Radcliffe Hospital, Oxford University Hospital NHS Trust, UK
Graeme Poston, School of Translational Studies, University of Liverpool, UK, Consultant Surgeon, Aintree University Hospital, UK
Richard Pötter, Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Austria
Thomas Powles, Experimental Cancer Medicine, Barts Cancer Institute, Barts and The London School of Medicine and Dentistry, UK
Hans Prenen, and Department of Oncology, University Hospitals Leuven, Catholic University, Belgium
Pieter Pretorius, Department of Neuroradiology, The John Radcliffe Hospital, Oxford University Hospitals NHS Trust, UK
Alexander Reinthaller, Medical University of Vienna, Austria
T Rieckmann, Laboratory of Radiobiology and Experimental Radio-oncology, University Medical Center Hamburg, Eppendorf, Germany
Angela Rogers, Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, UK
Geoffrey E. Rose, Adnexal Service, Moorfields Eye Hospital NHS Trust, London, UK
Jacob M Rowe, Rambam Health Care Campus and Technion, Israel Institute of Technology, Haifa, Israel
Campbell Roxburgh, School of Medicine, College of Medical Veterinary and Life Sciences, University of Glasgow, UK
Emiel Rutgers, Netherlands Cancer Institute, Amsterdam, The Netherlands
Xavier Sagaert, University Hospitals Leuven, Belgium
Manuel Salto-Tellez, Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell Biology, Queens University Belfast & Belfast Health Trust, Belfast, UK
Jonathan Samet, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Massoud Samiei, Programme of Action for Cancer Therapy (PACT), Vienna, Austria
Daniel Sargent, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA
Peter Schirmacher, Institute of Pathology, University Hospital, Heidelberg, Germany
Dirk Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Antwerp, Belgium
Christina Schütz, Faculty of Medicine, University of Tübingen, Germany
Maximilian Paul Scmid, Department of Radiation Oncology, Medical University of Vienna, Austria
Richard A. Scolyer, Royal Prince Alfred Hospital; Sydney Medical School, The University of Sydney; Melanoma Institute, Australia
Annekatrin Seidlitz, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany
Hans-Joerg Senn, Tumor and Breast Center ZeTuP, St.Gallen, Switzerland
Stefan Seregard, St Erik Eye Hospital, Karolinska Institutet, Stockholm, Sweden
Qian Shi, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Eric A. Singer, Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey, and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Elizabeth Smyth, Royal Marsden Hospital, London, UK
Cameron Snell, Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, UK
Carrie Snyder, Department of Preventive Medicine, Creighton University, Omaha, NE, USA
Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium
Robert James Campbell Steele, Division of Cancer, Medical Research Institute, School of Medicine, University of Dundee, UK
Nick Stern, Digestive Diseases Unit, Aintree University Hospital NHS Foundation Trust, Liverpool, UK
Graham Stevens, Department of Radiation Oncology, Orange Hospital, Orange, NSW, Australia
Jan Stöhlmacher-Williams, University Hospital Carl Gustav Carus, Technical University Dresden, Germany
Friedrich Stölzel, Department of Internal Medicine I, University Hospital Carl Gustav Carus Dresden, Germany
Paul H. Sugarbaker, Center for Gastrointestinal Malignancies, MedStar Washington Hospital Center, Washington, DC, USA
David Sugarbaker, Lung Institute, Baylor College of Medicine, Houston, TX, USA
Petra Sulentic, Department for Endocrinology and Diabetes, KBC "Sisters of Mercy", University of Zagreb, Croatia
Paul Sykes, Institute of Translational Medicine, University of Liverpool, Liverpool, UK
Martin S Tallman, Memorial Sloan Kettering Cancer Center, New York, USA
I Bing Tan, Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Anish Thomas, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
John Thompson, Melanoma Institute Australia, and Sydney Medical School, The University of Sydney, Australia
Klaus-Rüdiger Trott, Department of Oncology, University College London, UK
Lorenz Trümper, Georg August University, University Medicine Göttingen, Dep Hematology and Medical Oncology, Germany
Andreas Trumpp, Division of Stem Cells and Cancer, Heidelberg Institute of Stem Cell Technology and Experimental Medicine (HI-STEM), Germany
Keli Turner, Vanderbilt University School of Medicine, Nashville, TN, USA
Andrey Ugolkov, Center for Developmental Therapeutics, Northwestern University, Evanston, IL, USA
Brian Untch, Department of Surgery, Gastric and Mixed Tumor Service, Memorial Sloan Kettering Cancer Center, New York, USA
Catherine Uzan, Gustave Roussy, Villejuif, France
Eric Van Cutsem, Digestive Oncology, University Hospitals Leuven and KULeuven, Belgium
Cornelis J H van de Velde, Leiden University Medical Center, The Netherlands
C.B.M. (Colette) van den Broek, Leiden University Medical Center, Department of Surgery, The Netherlands
Fränzel van Duijnhoven, Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands
Vincent Vandecaveye, Department of Radiology, University Hospitals Leuven, Department of Imaging and Pathology, Catholic University of Leuven, Belgium
Vincent Vander Poorten, Department of Oncology, section Head and Neck Oncology, KU Leuven, Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven Cancer Institute, Belgium
Jan B Vermorken, Antwerp University Hospital, Edegem, Belgium
Jaap Verweij, Erasmus MC Cancer Institute, Rotterdam, The Netherlands
Giuseppe Viale, Department of Pathology, European Institute of Oncology, University of Milan School of Medicine, Milan, Italy
John Wass, Royal College of Physicians, and Oxford University Hospitals NHS Trust, UK
Andrew Weaver, Dept of Oncology, Oxford University Hospitals NHS Trust, UK
Walter Weder, Faculty of Medicine, University of Zurich, Switzerland
Anthony Weetman, Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, UK
Robert Weinberg, Whitehead Institute for Biomedical Research, Director, Ludwig/MIT Center for Molecular Oncology, MIT Department of Biology, Cambridge, MA, USA
Jürgen Weitz, Department of Visceral-, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany
Jens Werner, Department of General Surgery, University of Heidelberg, Germany
Bertram Wiedenmann, Charité University of Medicine, Berlin, Germany
Jennifer Wilding, University of Oxford, Department of Oncology, Weatherall Institute of Molecular Medicine, UK
Michelle D Williams, Department of Pathology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA
Pauline Wimberger, Department of Gynecology and Obstetrics, TU Dresden, Germany
Andrea Wolf, Department of Thoracic Surgery, The Mount Sinai Hospital, The Mount Sinai Health System, New York, USA
Gerald G. Wulf, Section Hematopoietic Stem Cell Transplantation, Haematology and Medical Oncology, Goettingen, Germany
Tristan D Yan, Royal Prince Alfred Hospital, Syndey, NSW, Australia
Rachel Yung, Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Nadia Zaffaroni, Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
Ghada Zakout, Cancer Institute, University College London, UK
John Zalcberg, School of Public Health and Preventive Medicine, Faculty of Medicine, Monash University, Melbourne, VIC, Australia
Dimitrios Zardavas, Breast International Group, Brussels, Belgium
Stefan Zimmermann, Oncology Department, HFR Fribourg - Hôpital cantonal, Fribourg, Switzerland

"I would recommend anyone considering buying an oncology textbook, and particularly those who work in oncology support services, to consider this textbook as it is well set out, easy to read, easy to comprehend, and covers all of the important aspects of modern day oncology." - Dr Andrew Davies, Consultant in Palliative Medicine, Royal Surrey County Hospital; Review for Supportive Care in Cancer

"An outstanding gift to the international scientific community... The new textbook is an excellent demonstration of this multifaceted and astonishingly variable problem, as well as of the latest achievements in its understanding and practical management." - Alexander A. Shtil, Recent Patents on Anticancer Drug Discovery

"This volume provides a comprehensive account of the multiple aspects of best practice in the discipline, making it an indispensable resource for oncologists of all grades and subspecialty interests." - Anticancer Research Vol. 36 (2016)

"The Oxford Textbook of Oncology is what it is meant to be: a textbook with comprehensive information of the actual status of oncology... an indispensable and attractive source of information." - Professor Jaak Ph. Janssens, European Journal of Cancer Prevention

"Reviews from the previous edition"

"The Oxford Textbook of Oncology is a classic and fresh approach to the field. It is a must for all libraries and all those who like to have a single up-to-date reference book that contains sufficient detail for the clinician in all subspecialties: surgery and chapters are sufficiently details to provide a reference for trainees in the field. " - Oncology, Volume 63, 2002

"The Oxford Textbook of Oncology covers virtually the entire spectrum of malignant diseases in adults and children. It meets very high editorial and production standards: the organization, illustrations, and eye-pleasing typography are outstanding... I have high praise for this textbook. " - NEJM, Volume 347, Number 2, 2002

"Under new editorship, the second edition is far more than an updated version of the first...the prose in the Oxford Textbook is exemplary...this textbook is unique among its peers in giving the sense that the authors are addressing the reader personally...an exception level of quality…Respect for the evidence-based medicine is apparent throughout the text...illustrative and anatomical drawing...of remarkable high quality...excellent discussion of doctor-patient communication in relation OT genetic counselling, psychological issues, and terminal cancers. " - JAMA, Volume 287, Issue 24, 2002

"A landmark reference…It sets new standards for publishing in oncology offering a ground-breaking innovative approach to the filed combined with the quality, accuracy , and intellectual rigour you have come to expect from the world's most prestigious reference publisher. " - Biomedicine and Pharmacotherapy, 2002

"This comprehensive textbook of oncology is the first new major textbook on cancer to appear in a decade and is designed for a broad audience of clinicians, oncologists in training, and academics. The coverage is comprehensive...The overall appearance of the book is outstanding. It is a welcome combination of epidemiology, aspects of basic science, pharmacology and radiation therapy that trainees will fine a nice change...should enjoy a wide readership...because of its appealing design and comprehensive approach to oncology. It is the most user-friendly comprehensive text currently available. The pathology, basic science, epidemiology, and radiation therapy sections are all presented with extreme clarity. " - Doody's Journal , 2002

"I recommend this book highly to all oncology and oncologists in training as a thorough, informative, and readable reference. Every large intuitional library and every oncology library should have it. " - NEJM, 2002

"Each chapter is nicely illustrated with schemes, cartoons and images. The text, although written by top oncologists, is readily understandable for a non-expert. Thus, the textbook will no doubt be appreciated by a broader audience." - Recent Patents on Anti-Cancer Drug Discovery Vol. 11 Issue No. 4, Alexander Shtil